Financhill
Sell
30

DXLG Quote, Financials, Valuation and Earnings

Last price:
$2.22
Seasonality move :
8.74%
Day range:
$2.17 - $2.28
52-week range:
$2.15 - $4.68
Dividend yield:
0%
P/E ratio:
14.53x
P/S ratio:
0.27x
P/B ratio:
0.81x
Volume:
449.2K
Avg. volume:
261.9K
1-year change:
-51.77%
Market cap:
$118.4M
Revenue:
$521.8M
EPS (TTM):
$0.15
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $474M $318.9M $505M $545.8M $521.8M
Revenue Growth (YoY) 0.06% -32.72% 58.34% 8.08% -4.4%
 
Cost of Revenues $269.8M $214.1M $255.2M $273.2M $269.4M
Gross Profit $204.2M $104.9M $249.8M $272.6M $252.4M
Gross Profit Margin 43.08% 32.88% 49.47% 49.94% 48.37%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $180.7M $129.1M $173M $198.8M $196.5M
Other Inc / (Exp) -$3.4M -$14.8M $2.3M $159K -$5.8M
Operating Expenses $205.2M $150.5M $190.2M $214.2M $210.4M
Operating Income -$1M -$45.7M $59.6M $58.4M $42.1M
 
Net Interest Expenses $3.3M $3.9M $4.4M $251K --
EBT. Incl. Unusual Items -$7.7M -$64.4M $57.6M $58.3M $38.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $105K $106K $917K -$30.8M $10.5M
Net Income to Company -$7.8M -$64.5M $56.7M $89.1M $27.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7.8M -$64.5M $56.7M $89.1M $27.9M
 
Basic EPS (Cont. Ops) -$0.16 -$1.26 $0.89 $1.42 $0.46
Diluted EPS (Cont. Ops) -$0.16 -$1.26 $0.83 $1.33 $0.43
Weighted Average Basic Share $50M $51.3M $63.4M $62.8M $61M
Weighted Average Diluted Share $50M $51.3M $68M $66.9M $64.3M
 
EBITDA $20.2M -$39M $76.9M $73.8M $55.9M
EBIT -$4.4M -$60.5M $59.6M $58.4M $42.1M
 
Revenue (Reported) $474M $318.9M $505M $545.8M $521.8M
Operating Income (Reported) -$1M -$45.7M $59.6M $58.4M $42.1M
Operating Income (Adjusted) -$4.4M -$60.5M $59.6M $58.4M $42.1M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $85.2M $121.5M $129.7M $119.2M $107.5M
Revenue Growth (YoY) -20.09% 42.64% 6.74% -8.08% -9.8%
 
Cost of Revenues $54.1M $60.5M $64.9M $62.6M $59.1M
Gross Profit $31.1M $61M $64.8M $56.6M $48.4M
Gross Profit Margin 36.48% 50.18% 49.98% 47.5% 45.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $32.8M $42M $48.4M $48M $47.4M
Other Inc / (Exp) $1.1M $1.1M -- -$57K --
Operating Expenses $38.1M $46.1M $52.2M $51.4M $51M
Operating Income -$7.1M $14.9M $12.7M $5.3M -$2.5M
 
Net Interest Expenses $1.1M $2.2M $107K -- --
EBT. Incl. Unusual Items -$7M $13.8M $12.6M $5.8M -$2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $27K $94K $2.1M $1.7M -$182K
Net Income to Company -$7M $13.7M $10.5M $4M -$1.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7M $13.7M $10.5M $4M -$1.8M
 
Basic EPS (Cont. Ops) -$0.14 $0.21 $0.17 $0.07 -$0.03
Diluted EPS (Cont. Ops) -$0.14 $0.20 $0.16 $0.06 -$0.03
Weighted Average Basic Share $51.5M $63.7M $62M $60.2M $57.1M
Weighted Average Diluted Share $51.5M $68.6M $66.2M $63.5M $57.1M
 
EBITDA -$613K $20.1M $16.4M $8.6M $1M
EBIT -$5.9M $15.9M $12.7M $5.3M -$2.5M
 
Revenue (Reported) $85.2M $121.5M $129.7M $119.2M $107.5M
Operating Income (Reported) -$7.1M $14.9M $12.7M $5.3M -$2.5M
Operating Income (Adjusted) -$5.9M $15.9M $12.7M $5.3M -$2.5M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $350.1M $471.7M $535.4M $528.6M $485M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $227.9M $249.2M $265M $272M $256.1M
Gross Profit $122.2M $222.5M $270.4M $256.5M $228.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $137.2M $159.2M $196.5M $198M $201.4M
Other Inc / (Exp) -$16.1M $2.5M $639K -$4.5M -$1.6M
Operating Expenses $159.3M $177.3M $212.5M $212M $215.2M
Operating Income -$37.1M $45.1M $57.9M $44.5M $13.6M
 
Net Interest Expenses $3.6M $5.3M $444K -- --
EBT. Incl. Unusual Items -$56.8M $42.3M $58.1M $41.5M $14.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $254K $583K -$32.6M $10.6M $4.9M
Net Income to Company -$57M $41.7M $90.7M $30.9M $9.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$57M $41.7M $90.7M $30.9M $9.6M
 
Basic EPS (Cont. Ops) -$1.12 $0.63 $1.44 $0.50 $0.17
Diluted EPS (Cont. Ops) -$1.12 $0.60 $1.35 $0.48 $0.15
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$31.1M $65.7M $71.8M $58.5M $27.4M
EBIT -$53.2M $47.6M $55.8M $44.5M $13.6M
 
Revenue (Reported) $350.1M $471.7M $535.4M $528.6M $485M
Operating Income (Reported) -$37.1M $45.1M $57.9M $44.5M $13.6M
Operating Income (Adjusted) -$53.2M $47.6M $55.8M $44.5M $13.6M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $218.8M $371.6M $402M $384.7M $347.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $153.1M $188.2M $198M $196.8M $183.5M
Gross Profit $65.8M $183.4M $204M $187.9M $164.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $90.7M $120.9M $144.4M $143.7M $148.6M
Other Inc / (Exp) -$15.2M $2.1M $398K -$4.2M --
Operating Expenses $107.1M $133.9M $156.2M $154M $158.8M
Operating Income -$41.3M $49.5M $47.8M $33.9M $5.5M
 
Net Interest Expenses $2.9M $4.3M $350K -- --
EBT. Incl. Unusual Items -$59.4M $47.4M $47.9M $31.1M $7.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $71K $548K -$32.9M $8.4M $2.8M
Net Income to Company -$59.5M $46.8M $80.8M $22.6M $4.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$59.5M $46.8M $80.8M $22.6M $4.4M
 
Basic EPS (Cont. Ops) -$1.17 $0.73 $1.29 $0.37 $0.08
Diluted EPS (Cont. Ops) -$1.17 $0.70 $1.21 $0.35 $0.07
Weighted Average Basic Share $153.4M $189.4M $188.8M $184.8M $173.4M
Weighted Average Diluted Share $153.4M $199.3M $201.3M $195.2M $179.2M
 
EBITDA -$40.1M $64.6M $59.6M $44.2M $15.7M
EBIT -$56.5M $51.6M $47.8M $33.9M $5.5M
 
Revenue (Reported) $218.8M $371.6M $402M $384.7M $347.8M
Operating Income (Reported) -$41.3M $49.5M $47.8M $33.9M $5.5M
Operating Income (Adjusted) -$56.5M $51.6M $47.8M $33.9M $5.5M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $4.3M $19M $15.5M $52.1M $27.6M
Short Term Investments -- -- -- -- $32.5M
Accounts Receivable, Net $6.2M $6.4M $2.1M $1.7M $3.9M
Inventory $102.4M $85M $81.8M $93M $81M
Prepaid Expenses -- -- -- -- --
Other Current Assets $10.9M $3.7M $6.6M $7.2M $8.3M
Total Current Assets $123.9M $114.1M $106M $154M $153.2M
 
Property Plant And Equipment $264.7M $190.9M $172.3M $163.4M $181.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.2M $602K $559K $563K $457K
Total Assets $390.9M $306.8M $280M $350.6M $357.7M
 
Accounts Payable $31.8M $27.1M $25.2M $27.5M $17.4M
Accrued Expenses $18.1M $24.8M $35.1M $36.9M $35.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $41.2M $43.6M $35.2M $37.3M $37.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $130.4M $155M $95.5M $101.8M $89.9M
 
Long-Term Debt $14.8M $14.9M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $332.5M $310.8M $221.7M $213.4M $208.8M
 
Common Stock $633K $647K $770K $782K $790K
Other Common Equity Adj -$6.4M -$6.2M -$5.5M -$4.9M --
Common Equity $58.4M -$4.1M $58.2M $137.2M $149M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $58.4M -$4.1M $58.2M $137.2M $149M
 
Total Liabilities and Equity $390.9M $306.8M $280M $350.6M $357.7M
Cash and Short Terms $4.3M $19M $15.5M $52.1M $60M
Total Debt $54.1M $74.4M -- -- --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $21.4M $6.9M $23.5M $10.7M $7.1M
Short Term Investments -- -- -- $49.6M $35.9M
Accounts Receivable, Net $5.2M $1.6M $1M $3M $840K
Inventory $94.9M $82.3M $106.8M $99.9M $89.1M
Prepaid Expenses -- -- -- -- --
Other Current Assets $5.5M $6.9M $8.5M $7.3M $7.3M
Total Current Assets $127.1M $97.8M $139.8M $170.5M $140.3M
 
Property Plant And Equipment $208.2M $164.5M $165.5M $178.3M $219.8M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $540K $567K $563K $451K $503K
Total Assets $336.9M $263.9M $340.5M $372.7M $381.3M
 
Accounts Payable $28.6M $29.8M $26.6M $28.3M $28M
Accrued Expenses $22.8M $32.8M $34.2M $31.9M $26.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $45.6M $37.2M $36.7M $40.8M $35.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $165.1M $99.7M $97.5M $101M $89.6M
 
Long-Term Debt $14.9M -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $335.9M $216.2M $213.1M $221.9M $235.9M
 
Common Stock $643K $768K $781K $789K $794K
Other Common Equity Adj -$5.7M -$6M -$5.3M -$1.7M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.1M $47.7M $127.4M $150.8M $145.5M
 
Total Liabilities and Equity $336.9M $263.9M $340.5M $372.7M $381.3M
Cash and Short Terms $21.4M $6.9M $23.5M $60.4M $43M
Total Debt $82.9M -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -$7.8M -$64.5M $56.7M $89.1M $27.9M
Depreciation & Amoritzation $24.6M $21.5M $17.2M $15.4M $13.8M
Stock-Based Compensation $2.5M $1.8M $1.6M $1.9M $2.9M
Change in Accounts Receivable -$1.2M -$197K $4.3M $390K -$2.8M
Change in Inventories $4.4M $17.4M $3.3M -$11.2M $12M
Cash From Operations $15.8M -$1.2M $75.5M $59.9M $49.6M
 
Capital Expenditures $13.4M $4.2M $5.3M $9.6M $17.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$13.4M -$4.2M -$5.3M -$9.6M -$49.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $57.8M -- --
Long-Term Debt Repaid -- -- -$132.5M -- --
Repurchase of Common Stock -- -- -- -$12.7M -$24.5M
Other Financing Activities -$244K -$25K -$4.2M -$1.8M -$759K
Cash From Financing -$2.9M $20.1M -$73.8M -$13.7M -$24.9M
 
Beginning Cash (CF) $4.9M $4.3M $19M $15.5M $52.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$530K $14.7M -$3.5M $36.6M -$24.5M
Ending Cash (CF) $4.3M $19M $15.5M $52.1M $27.6M
 
Levered Free Cash Flow $2.4M -$5.5M $70.3M $50.3M $32.2M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$7M $13.7M $10.5M $4M -$1.8M
Depreciation & Amoritzation $5.3M $4.1M $3.8M $3.4M $3.6M
Stock-Based Compensation $446K $372K $425K $912K $619K
Change in Accounts Receivable -$2.6M $406K $434K -$2.8M -$62K
Change in Inventories -$7.5M -$8.9M -$10.1M -$12.3M -$10.5M
Cash From Operations $361K $21.9M $6.3M $6.9M -$3.5M
 
Capital Expenditures $810K $1.1M $3.8M $5.7M $6.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$810K -$1.1M -$3.8M -$11.1M -$623K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$17.5M -- -- --
Repurchase of Common Stock -- -- -- -$4M -$10.2M
Other Financing Activities -- -$2.6M -$1.4M -$312K -$17K
Cash From Financing $1.5M -$19.7M -$1.2M -$4.3M -$10.2M
 
Beginning Cash (CF) $20.4M $5.8M $22.2M $19.2M $21.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1M $1.1M $1.3M -$8.5M -$14.4M
Ending Cash (CF) $21.4M $6.9M $23.5M $10.7M $7.1M
 
Levered Free Cash Flow -$449K $20.8M $2.5M $1.1M -$10.1M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$57M $41.7M $90.7M $30.9M $9.6M
Depreciation & Amoritzation $22.1M $18.1M $15.9M $14M $13.7M
Stock-Based Compensation $2M $1.7M $1.8M $2.4M $3.6M
Change in Accounts Receivable -$721K $3.6M $588K -$2.7M $2M
Change in Inventories $25.3M $12.6M -$24.5M $7M $10.7M
Cash From Operations $21.6M $71.6M $41.6M $62.9M $28.9M
 
Capital Expenditures $5.4M $4.1M $10.3M $12.2M $26.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$5.4M -$4.1M -$10.3M -$60.9M -$12.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $17.5M -- -- --
Long-Term Debt Repaid -- -$92.2M -- -- --
Repurchase of Common Stock -- -- -$12.7M -$14.9M -$20.1M
Other Financing Activities -$25K -$3.4M -$2.6M -$758K -$66K
Cash From Financing -$253K -$81.9M -$14.7M -$14.7M -$20M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $16M -$14.5M $16.5M -$12.8M -$3.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $16.2M $67.5M $31.2M $50.7M $2.5M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$59.5M $46.8M $80.8M $22.6M $4.4M
Depreciation & Amoritzation $16.4M $13M $11.7M $10.3M $10.2M
Stock-Based Compensation $1.4M $1.2M $1.4M $1.9M $2.6M
Change in Accounts Receivable $997K $4.8M $1.1M -$2M $2.8M
Change in Inventories $7.5M $2.7M -$25.1M -$6.9M -$8.2M
Cash From Operations -$8.6M $64.2M $30.2M $33.1M $12.5M
 
Capital Expenditures $2.9M $2.8M $7.9M $10.4M $19.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.9M -$2.8M -$7.9M -$59.1M -$22.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $17.5M -- -- --
Long-Term Debt Repaid -- -$92.2M -- -- --
Repurchase of Common Stock -- -- -$12.7M -$14.9M -$10.4M
Other Financing Activities -$25K -$3.4M -$1.8M -$758K -$65K
Cash From Financing $28.7M -$73.4M -$14.3M -$15.3M -$10.4M
 
Beginning Cash (CF) $50.9M $30.7M $45.2M $101.3M $65.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $17.1M -$12.1M $8M -$41.4M -$20.5M
Ending Cash (CF) $68M $18.6M $53.2M $59.9M $44.9M
 
Levered Free Cash Flow -$11.6M $61.3M $22.3M $22.7M -$7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock